An expert opinion from the european society of hypertension-european union geriatric medicine society working group on the management of hypertension in very old, frail subjects

Hypertension

Volumn 67, Issue 5, 2016, Pages 820-825

  Benetos, Athanase ^a   Bulpitt, Christopher J ^b   Petrovic, Mirko ^c   Ungar, Andrea ^d   Rosei, Enrico Agabiti ^e   Cherubini, Antonio ^f   Redon, Josep ^g   Grodzicki, Tomasz ^h   Dominiczak, Anna ⁱ   Strandberg, Timo ^j,k   Mancia, Giuseppe ^l  

^a UNIVERSITÉ DE LORRAINE   (France)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d CAREGGI UNIVERSITY HOSPITAL   (Italy)

^e UNIVERSITY OF BRESCIA   (Italy)

^f INRCA   (Italy)

^g UNIVERSITY OF VALENCIA   (Spain)

^h JAGIELLONIAN UNIVERSITY   (Poland)

ⁱ UNIVERSITY OF GLASGOW   (United Kingdom)

^j UNIVERSITY OF HELSINKI   (Finland)

^k UNIVERSITY OF OULU   (Finland)

^l UNIVERSITY OF MILANO BICOCCA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; EUROPEAN UNION; FRAIL ELDERLY; GERIATRICS; HUMAN; HYPERTENSION; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); AGED; BLOOD PRESSURE MEASUREMENT; DISEASE MANAGEMENT; EXPERT WITNESS; FEMALE; GERIATRIC ASSESSMENT; MALE; MEDICAL SOCIETY; MORTALITY; PROCEDURES; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STANDARDS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; DISEASE MANAGEMENT; EUROPEAN UNION; EXPERT TESTIMONY; FEMALE; FRAIL ELDERLY; GERIATRIC ASSESSMENT; GERIATRICS; HUMANS; HYPERTENSION; MALE; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SOCIETIES, MEDICAL; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84961221157     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.07020     Document Type: Note

References (46)

1. Authors/Task Force Memebers Mancia G, Fagard R, Narkiewicz K, Authors/Task Force Memebers 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013 34 2159 2219
2. National Institute on Aging, National Institutes of Health. Global Health and Aging. NIH Publication no. 11-7737. 2011 Washington, DC World Health Organisation
3. Health at a Glance 2009-OECD Indicators. http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0CCIQFjAA&url=http%3A%2F%2Fwww.oecd.org%2Fhealth%2Fhealth-systems%2F44117530.pdf&ei=DvK7VN7SJMXkasibgrAI&usg=AFQjCNHKC9qNe87Gdi-BIi-VTS0dfWpigg&bvm=bv.83829542,d.d2s&cad=rja). Accessed October 2015
4. Berrut G, Andrieu S, Araujo De Carvalho I, Promoting access to innovation for frail old persons. IAGG (International Association of Gerontology and Geriatrics), WHO (World Health Organization) and SFGG (Societe Francaise de Geriatrie et de Gerontologie) Workshop-Athens January 20-21, 2012. J Nutr Health Aging 2013 17 688 693
5. Weber MA, Schiffrin EL, White WB, Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens 2014 32 3 15. doi: 10.1097/HJH.0000000000000065
6. Aronow WS, Fleg JL, Pepine CJ, ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Soc Hypertens 2011 5 259 352. doi: 10.1016/j.jash.2011.06.001
7. National Institute for Health and Care Excellence. http://www.nice.org.uk/guidance/cg127/resources/guidance-hypertension-pdf. Accessed October 2015
8. Blacher J, Halimi JM, Hanon O, Mourad JJ, Pathak A, Schnebert B, Girerd X, French Society of Hypertension Management of hypertension in adults: the 2013 French Society of Hypertension guidelines. Fundam Clin Pharmacol 2014 28 1 9. doi: 10.1111/fcp.12044
9. Beckett N, Peters R, Tuomilehto J, Swift C, Sever P, Potter J, McCormack T, Forette F, Gil-Extremera B, Dumitrascu D, Staessen JA, Thijs L, Fletcher A, Bulpitt C, HYVET Study Group Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial. BMJ 2012 344 d7541
10. Warwick J, Falaschetti E, Rockwood K, Mitnitski A, Thijs L, Beckett N, Bulpitt C, Peters R, No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Med 2015 13 78. doi: 10.1186/s12916-015-0328-1
11. Odden MC, Covinsky KE, Neuhaus JM, Mayeda ER, Peralta CA, Haan MN, The association of blood pressure and mortality differs by self-reported walking speed in older Latinos. J Gerontol A Biol Sci Med Sci 2012 67 977 983. doi: 10.1093/gerona/glr245
12. Ogliari G, Westendorp RG, Muller M, Mari D, Torresani E, Felicetta I, Lucchi T, Rossi PD, Sabayan B, de Craen AJ, Blood pressure and 10-year mortality risk in the Milan Geriatrics 75+ Cohort Study: role of functional and cognitive status. Age Ageing 2015 44 932 937. doi: 10.1093/ageing/afv141
13. Benetos A, Buatois S, Salvi P, Blood pressure and pulse wave velocity values in the institutionalized elderly aged 80 and over: baseline of the PARTAGE study. J Hypertens 2010 28 41 50. doi: 10.1097/HJH.0b013e328332b879
14. Benetos A, Gautier S, Labat C, Mortality and cardiovascular events are best predicted by low central/peripheral pulse pressure amplification but not by high blood pressure levels in elderly nursing home subjects: the PARTAGE (Predictive Values of Blood Pressure and Arterial Stiffness in Institutionalized Very Aged Population) study. J Am Coll Cardiol 2012 60 1503 1511. doi: 10.1016/j.jacc.2012.04.055
15. Benetos A, Labat C, Rossignol P, Fay R, Rolland Y, Valbusa F, Salvi P, Zamboni M, Manckoundia P, Hanon O, Gautier S, Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents: The PARTAGE Study. JAMA Intern Med 2015 175 989 995. doi: 10.1001/jamainternmed.2014.8012
16. Mossello E, Pieraccioli M, Nesti N, Bulgaresi M, Lorenzi C, Caleri V, Tonon E, Cavallini MC, Baroncini C, Di Bari M, Baldasseroni S, Cantini C, Biagini CA, Marchionni N, Ungar A, Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs. JAMA Intern Med 2015 175 578 585. doi: 10.1001/jamainternmed.2014.8164
17. Fedorowski A, Stavenow L, Hedblad B, Berglund G, Nilsson PM, Melander O, Orthostatic hypotension predicts all-cause mortality and coronary events in middle-Aged individuals (The Malmo Preventive Project). Eur Heart J 2010 31 85 91. doi: 10.1093/eurheartj/ehp329
18. Angelousi A, Girerd N, Benetos A, Frimat L, Gautier S, Weryha G, Boivin JM, Association between orthostatic hypotension and cardiovascular risk, cerebrovascular risk, cognitive decline and falls as well as overall mortality: a systematic review and meta-Analysis. J Hypertens 2014 32 1562 1571. discussion 1571. doi: 10.1097/HJH.0000000000000235
19. Butt DA, Mamdani M, Austin PC, Tu K, Gomes T, Glazier RH, The risk of hip fracture after initiating antihypertensive drugs in the elderly. Arch Intern Med 2012 172 1739 1744. doi: 10.1001/2013.jamainternmed.469
20. van der Wardt V, Logan P, Conroy S, Harwood R, Gladman J, Antihypertensive treatment in people with dementia. J Am Med Dir Assoc 2014 15 620 629. doi: 10.1016/j.jamda.2014.03.005
21. Muller M, Smulders YM, de Leeuw PW, Stehouwer CD, Treatment of hypertension in the oldest old: a critical role for frailty? Hypertension 2014 63 433 441. doi: 10.1161/HYPERTENSIONAHA.113.00911
22. Corrao G, Mazzola P, Monzio Compagnoni M, Rea F, Merlino L, Annoni G, Mancia G, Antihypertensive Medications, Loop Diuretics, and Risk of Hip Fracture in the Elderly: A Population-Based Cohort Study of 81,617 Italian Patients Newly Treated Between 2005 and 2009. Drugs Aging 2015 32 927 936. doi: 10.1007/s40266-015-0306-5
23. Rakugi H, Ogihara T, Goto Y, Ishii M, JATOS Study Group Comparison of strict-And mild-blood pressure control in elderly hypertensive patients: a per-protocol analysis of JATOS. Hypertens Res 2010 33 1124 1128. doi: 10.1038/hr.2010.144
24. Ogihara T, Saruta T, Rakugi H, Matsuoka H, Shimamoto K, Shimada K, Imai Y, Kikuchi K, Ito S, Eto T, Kimura G, Imaizumi T, Takishita S, Ueshima H, Valsartan in Elderly Isolated Systolic Hypertension Study Group Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study. Hypertension 2010 56 196 202. doi: 10.1161/HYPERTENSIONAHA.109.146035
25. Foster-Dingley JC, Moonen JE, de Craen AJ, de Ruijter W, van der Mast RC, van der Grond J, Blood pressure is not associated with cerebral blood flow in older persons. Hypertension 2015 66 954 960. doi: 10.1161/HYPERTENSIONAHA.115.05799
26. Lipsitz LA, Habtemariam D, Gagnon M, Iloputaife I, Sorond F, Tchalla AE, Dantoine TF, Travison TG, Reexamining the effect of antihypertensive medications on falls in old age. Hypertension 2015 66 183 189. doi: 10.1161/HYPERTENSIONAHA.115.05513
27. SPRINT Research Group Wright JT Jr, Williamson JD, Whelton PK, SPRINT Research Group A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015 373 2103 2116
28. Mancia G, The SPRINT trial: cons. http://www.acc.org/latest-in-cardiology/articles/2015/12/01/10/04/the-sprint-Trial-cons. Accessed January 26, 2016
29. Touyz RM, Dominiczak AF, Successes of SPRINT, but Still Some Hurdles to Cross. Hypertension 2016 67 268 269. doi: 10.1161/HYPERTENSIONAHA.115.06725
30. Ogihara T, Saruta T, Rakugi H, Saito I, Shimamoto K, Matsuoka H, Teramukai S, Higaki J, Ito S, Shimada K, COLM Investigators Combination therapy of hypertension in the elderly: a subgroup analysis of the Combination of OLMesartan and a calcium channel blocker or diuretic in Japanese elderly hypertensive patients trial. Hypertens Res 2015 38 89 96. doi: 10.1038/hr.2014.144
31. Blood Pressure Lowering Treatment Trialists' Collaboration Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med 2005 165 1410 1419
32. Khan N, McAlister FA, Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-Analysis. CMAJ 2006 174 1737 1742. doi: 10.1503/cmaj.060110
33. Wiysonge CS, Bradley H, Mayosi BM, Maroney R, Mbewu A, Opie LH, Volmink J, Beta-blockers for hypertension. Cochrane Database Syst Rev 2007 1 CD002003
34. Ebert TJ, Morgan BJ, Barney JA, Denahan T, Smith JJ, Effects of aging on baroreflex regulation of sympathetic activity in humans. Am J Physiol 1992 263 3 pt 2 H798 H803
35. Maher RL, Hanlon J, Hajjar ER, Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf 2014 13 57 65. doi: 10.1517/14740338.2013.827660
36. Benetos A, Rossignol P, Cherubini A, Joly L, Grodzicki T, Rajkumar C, Strandberg TE, Petrovic M, Polypharmacy in the aging patient: management of hypertension in octogenarians. JAMA 2015 314 170 180. doi: 10.1001/jama.2015.7517
37. Mancia G, Zambon A, Soranna D, Merlino L, Corrao G, Factors involved in the discontinuation of antihypertensive drug therapy: an analysis from real life data. J Hypertens 2014 32 1708 1715. discussion 1716. doi: 10.1097/HJH.0000000000000222
38. Goldberg RM, Mabee J, Chan L, Wong S, Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med 1996 14 447 450. doi: 10.1016/S0735-6757(96)90147-3
39. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA, Cardiovascular Health Study Collaborative Research Group Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001 56 M146 M156
40. Studenski S, Perera S, Patel K, Gait speed and survival in older adults. JAMA 2011 305 50 58. doi: 10.1001/jama.2010.1923
41. Romero-Ortuno R, Soraghan C, A Frailty Instrument for primary care for those aged 75 years or more: findings from the Survey of Health, Ageing and Retirement in Europe, a longitudinal population-based cohort study (SHARE-FI75+). BMJ Open 2014 4 e006645. doi: 10.1136/bmjopen-2014-006645
42. Abellan van Kan G, Rolland Y, Bergman H, Morley JE, Kritchevsky SB, Vellas B, The I.A.N.A Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging 2008 12 29 37
43. Zhang Y, Agnoletti D, Xu Y, Wang JG, Blacher J, Safar ME, Carotid-femoral pulse wave velocity in the elderly. J Hypertens 2014 32 1572 6. discussion 1576. doi: 10.1097/HJH.0000000000000187
44. O'Brien E, Parati G, Stergiou G, European Society of Hypertension Working Group on Blood Pressure Monitoring European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 2013 31 1731 1768. doi: 10.1097/HJH.0b013e328363e964
45. Mancia G, Parati G, Bilo G, Ambulatory blood pressure values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET). Hypertension 2012 60 1400 1406. doi: 10.1161/HYPERTENSIONAHA.112.199562
46. Gale CR, Cooper C, Sayer AA, Prevalence of frailty and disability: findings from the English Longitudinal Study of Ageing. Age Ageing 2015 44 162 165. doi: 10.1093/ageing/afu148